Dmitry Gerashchenko, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nitric Oxide Synthase Type I | 5 | 2019 | 169 | 1.530 |
Why?
|
| Sleep | 22 | 2023 | 4646 | 1.270 |
Why?
|
| Cerebral Cortex | 9 | 2019 | 5716 | 0.810 |
Why?
|
| Neuropeptides | 9 | 2011 | 941 | 0.780 |
Why?
|
| Neurons | 16 | 2022 | 9289 | 0.730 |
Why?
|
| Sleep Deprivation | 7 | 2018 | 823 | 0.700 |
Why?
|
| Delta Rhythm | 1 | 2019 | 77 | 0.660 |
Why?
|
| Hypothalamic Area, Lateral | 3 | 2010 | 105 | 0.610 |
Why?
|
| Somatostatin | 1 | 2019 | 443 | 0.590 |
Why?
|
| Substance P | 1 | 2017 | 332 | 0.540 |
Why?
|
| Wakefulness | 10 | 2022 | 1240 | 0.520 |
Why?
|
| Cholera Toxin | 1 | 2017 | 557 | 0.490 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2011 | 2855 | 0.450 |
Why?
|
| Interneurons | 4 | 2022 | 582 | 0.440 |
Why?
|
| Telemetry | 1 | 2013 | 198 | 0.400 |
Why?
|
| Opioid Peptides | 1 | 2010 | 37 | 0.380 |
Why?
|
| Receptors, Opioid | 1 | 2010 | 143 | 0.360 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2014 | 594 | 0.360 |
Why?
|
| Hypothalamus | 3 | 2004 | 992 | 0.360 |
Why?
|
| Memory | 1 | 2019 | 2165 | 0.340 |
Why?
|
| Pain Perception | 1 | 2010 | 193 | 0.330 |
Why?
|
| Sleep Stages | 1 | 2013 | 673 | 0.330 |
Why?
|
| Neuronal Plasticity | 1 | 2017 | 1420 | 0.320 |
Why?
|
| Interleukin-1beta | 1 | 2014 | 972 | 0.320 |
Why?
|
| Proto-Oncogene Proteins c-fos | 4 | 2018 | 571 | 0.300 |
Why?
|
| Polysomnography | 3 | 2017 | 1788 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 13 | 2014 | 8125 | 0.280 |
Why?
|
| Electroencephalography | 10 | 2022 | 6072 | 0.270 |
Why?
|
| Analgesia | 1 | 2010 | 448 | 0.270 |
Why?
|
| Narcolepsy | 2 | 2011 | 196 | 0.270 |
Why?
|
| Movement | 1 | 2013 | 1464 | 0.270 |
Why?
|
| Immunotoxins | 3 | 2017 | 178 | 0.250 |
Why?
|
| Animals | 34 | 2024 | 166331 | 0.230 |
Why?
|
| Homeostasis | 3 | 2010 | 3260 | 0.230 |
Why?
|
| Stress, Physiological | 1 | 2010 | 1386 | 0.220 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 4335 | 0.210 |
Why?
|
| Histamine | 1 | 2004 | 498 | 0.210 |
Why?
|
| Phytochrome | 1 | 2022 | 8 | 0.210 |
Why?
|
| Gene Expression Regulation | 3 | 2017 | 11839 | 0.210 |
Why?
|
| Mice | 18 | 2024 | 80087 | 0.200 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2024 | 686 | 0.190 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 1998 | 105 | 0.180 |
Why?
|
| Brain | 3 | 2017 | 26596 | 0.180 |
Why?
|
| Mice, Transgenic | 5 | 2023 | 9441 | 0.180 |
Why?
|
| Rats | 14 | 2013 | 23680 | 0.170 |
Why?
|
| Electromyography | 5 | 2018 | 1374 | 0.160 |
Why?
|
| Plant Proteins | 3 | 2007 | 366 | 0.160 |
Why?
|
| Infusions, Intraventricular | 1 | 2017 | 34 | 0.150 |
Why?
|
| Ribosome Inactivating Proteins, Type 1 | 3 | 2007 | 27 | 0.150 |
Why?
|
| Alzheimer Disease | 3 | 2023 | 8304 | 0.150 |
Why?
|
| Arousal | 3 | 2009 | 1146 | 0.150 |
Why?
|
| Aqueous Humor | 1 | 1998 | 153 | 0.140 |
Why?
|
| Ciliary Body | 1 | 1998 | 166 | 0.140 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2017 | 128 | 0.140 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 2192 | 0.140 |
Why?
|
| Iris | 1 | 1998 | 231 | 0.140 |
Why?
|
| Adenosine | 3 | 2008 | 819 | 0.130 |
Why?
|
| Carrier Proteins | 3 | 2004 | 4926 | 0.130 |
Why?
|
| Amyloidosis | 1 | 2022 | 803 | 0.130 |
Why?
|
| Photic Stimulation | 1 | 2022 | 1973 | 0.130 |
Why?
|
| Vitreous Body | 1 | 1998 | 397 | 0.130 |
Why?
|
| Periodicity | 2 | 2007 | 348 | 0.120 |
Why?
|
| Circadian Rhythm | 5 | 2008 | 2532 | 0.120 |
Why?
|
| Evoked Potentials | 1 | 2018 | 1010 | 0.100 |
Why?
|
| Cell Count | 3 | 2013 | 1831 | 0.100 |
Why?
|
| Inflammasomes | 1 | 2017 | 515 | 0.100 |
Why?
|
| Subthalamus | 1 | 2011 | 4 | 0.100 |
Why?
|
| Male | 19 | 2024 | 351093 | 0.090 |
Why?
|
| Cataplexy | 1 | 2011 | 61 | 0.090 |
Why?
|
| Microinjections | 1 | 2010 | 322 | 0.090 |
Why?
|
| Mice, Inbred C57BL | 3 | 2024 | 21529 | 0.090 |
Why?
|
| Brain Waves | 1 | 2013 | 393 | 0.080 |
Why?
|
| Hypnotics and Sedatives | 1 | 2017 | 1161 | 0.080 |
Why?
|
| Thyrotropin-Releasing Hormone | 1 | 2009 | 139 | 0.080 |
Why?
|
| Restraint, Physical | 1 | 2010 | 184 | 0.080 |
Why?
|
| Hippocampus | 2 | 2022 | 3685 | 0.080 |
Why?
|
| Mesocricetus | 1 | 2008 | 250 | 0.080 |
Why?
|
| Mice, Knockout | 3 | 2019 | 14211 | 0.080 |
Why?
|
| Prostaglandin D2 | 1 | 2008 | 109 | 0.080 |
Why?
|
| Alpha Rhythm | 1 | 2008 | 109 | 0.080 |
Why?
|
| Nitric Oxide Synthase | 1 | 2011 | 910 | 0.070 |
Why?
|
| Microscopy, Electron | 1 | 2010 | 2563 | 0.070 |
Why?
|
| Toxins, Biological | 2 | 2004 | 61 | 0.070 |
Why?
|
| Pigment Epithelium of Eye | 2 | 1998 | 211 | 0.070 |
Why?
|
| Brain Chemistry | 2 | 2008 | 965 | 0.070 |
Why?
|
| Receptors, Purinergic P1 | 1 | 2006 | 108 | 0.070 |
Why?
|
| Immunohistochemistry | 5 | 2013 | 11036 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2008 | 1267 | 0.060 |
Why?
|
| RNA, Messenger | 4 | 2014 | 12741 | 0.060 |
Why?
|
| Hypothalamus, Posterior | 1 | 2004 | 12 | 0.060 |
Why?
|
| Statistics, Nonparametric | 1 | 2010 | 2841 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6220 | 0.060 |
Why?
|
| Inflammation | 1 | 2004 | 10592 | 0.060 |
Why?
|
| Cricetinae | 1 | 2008 | 2426 | 0.060 |
Why?
|
| Prosencephalon | 1 | 2006 | 300 | 0.060 |
Why?
|
| Gene Expression | 1 | 2017 | 7580 | 0.060 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2010 | 1123 | 0.060 |
Why?
|
| Muscle Tonus | 1 | 2004 | 82 | 0.060 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 2003 | 191 | 0.060 |
Why?
|
| Injections, Intraventricular | 1 | 2003 | 224 | 0.060 |
Why?
|
| Sleep, REM | 2 | 2004 | 589 | 0.060 |
Why?
|
| Receptors, Neuropeptide | 1 | 2003 | 105 | 0.050 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 627 | 0.050 |
Why?
|
| Action Potentials | 2 | 2009 | 1772 | 0.050 |
Why?
|
| Adenosine Deaminase | 1 | 2004 | 248 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2024 | 17834 | 0.050 |
Why?
|
| Amyloidogenic Proteins | 1 | 2022 | 150 | 0.050 |
Why?
|
| Nitric Oxide | 1 | 2010 | 2122 | 0.050 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2001 | 39 | 0.050 |
Why?
|
| MicroRNAs | 1 | 2017 | 3742 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2009 | 1843 | 0.050 |
Why?
|
| Nerve Tissue Proteins | 2 | 2004 | 4394 | 0.050 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2024 | 467 | 0.050 |
Why?
|
| Pain Measurement | 1 | 2010 | 3437 | 0.050 |
Why?
|
| Neurotransmitter Agents | 1 | 2004 | 648 | 0.040 |
Why?
|
| Preoptic Area | 1 | 2001 | 131 | 0.040 |
Why?
|
| Lipocalins | 2 | 1998 | 159 | 0.040 |
Why?
|
| Nerve Degeneration | 1 | 2003 | 740 | 0.040 |
Why?
|
| Plaque, Amyloid | 1 | 2022 | 740 | 0.040 |
Why?
|
| Amyloid beta-Protein Precursor | 1 | 2023 | 1100 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 427 | 0.040 |
Why?
|
| Isomerases | 1 | 1996 | 55 | 0.040 |
Why?
|
| In Situ Hybridization | 2 | 1998 | 1900 | 0.030 |
Why?
|
| Salivary Proteins and Peptides | 1 | 1996 | 48 | 0.030 |
Why?
|
| Mammals | 1 | 2022 | 1126 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2003 | 1215 | 0.030 |
Why?
|
| Light | 1 | 2022 | 1334 | 0.030 |
Why?
|
| Thalamus | 1 | 2022 | 1010 | 0.030 |
Why?
|
| Period Circadian Proteins | 2 | 2008 | 96 | 0.030 |
Why?
|
| Photoreceptor Cells | 1 | 1996 | 236 | 0.030 |
Why?
|
| Lens, Crystalline | 1 | 1998 | 389 | 0.030 |
Why?
|
| Microglia | 1 | 2023 | 1310 | 0.030 |
Why?
|
| Calcium | 2 | 2023 | 5654 | 0.030 |
Why?
|
| Phenethylamines | 2 | 2008 | 95 | 0.030 |
Why?
|
| Cell Survival | 1 | 2004 | 5761 | 0.030 |
Why?
|
| Receptor, Adenosine A2A | 2 | 2008 | 128 | 0.030 |
Why?
|
| Cerebrovascular Circulation | 1 | 2024 | 2713 | 0.030 |
Why?
|
| Neural Pathways | 1 | 2004 | 3013 | 0.030 |
Why?
|
| Body Temperature | 2 | 2009 | 767 | 0.030 |
Why?
|
| Nuclear Proteins | 2 | 2008 | 5746 | 0.030 |
Why?
|
| Blotting, Western | 2 | 1998 | 5048 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2024 | 8294 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2022 | 3687 | 0.030 |
Why?
|
| Amyloid beta-Peptides | 1 | 2023 | 3742 | 0.020 |
Why?
|
| Miniature Postsynaptic Potentials | 1 | 2009 | 17 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2004 | 6594 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 6095 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 1996 | 1710 | 0.020 |
Why?
|
| Flavoproteins | 1 | 2008 | 40 | 0.020 |
Why?
|
| Cryptochromes | 1 | 2008 | 47 | 0.020 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2008 | 30 | 0.020 |
Why?
|
| CLOCK Proteins | 1 | 2008 | 85 | 0.020 |
Why?
|
| Motor Activity | 2 | 2009 | 2666 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2022 | 23112 | 0.020 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 937 | 0.020 |
Why?
|
| Phenotype | 1 | 2004 | 16245 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2011 | 1202 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 1756 | 0.020 |
Why?
|
| Aging | 1 | 2004 | 8486 | 0.020 |
Why?
|
| Cell Cycle Proteins | 2 | 2008 | 3408 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2008 | 1858 | 0.010 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2004 | 68 | 0.010 |
Why?
|
| Phosphopyruvate Hydratase | 1 | 2004 | 125 | 0.010 |
Why?
|
| Species Specificity | 1 | 2008 | 2410 | 0.010 |
Why?
|
| Radioimmunoassay | 1 | 2004 | 871 | 0.010 |
Why?
|
| Genotype | 2 | 2011 | 12773 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2004 | 817 | 0.010 |
Why?
|
| Pons | 1 | 2004 | 239 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2008 | 1752 | 0.010 |
Why?
|
| Stroke | 1 | 2024 | 9693 | 0.010 |
Why?
|
| Norepinephrine | 1 | 2004 | 881 | 0.010 |
Why?
|
| Subarachnoid Space | 1 | 2001 | 79 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2001 | 221 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2008 | 3784 | 0.010 |
Why?
|
| Electrodes, Implanted | 1 | 2004 | 820 | 0.010 |
Why?
|
| Humans | 4 | 2023 | 746044 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2008 | 2846 | 0.010 |
Why?
|
| Lipocalin 1 | 1 | 1996 | 2 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4576 | 0.010 |
Why?
|
| Transcription Factors | 2 | 2008 | 12039 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1996 | 1547 | 0.010 |
Why?
|
| Alleles | 1 | 2004 | 6831 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1996 | 2288 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10718 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2001 | 2042 | 0.010 |
Why?
|
| Female | 3 | 2009 | 382109 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 9105 | 0.000 |
Why?
|
| Retina | 1 | 1996 | 2615 | 0.000 |
Why?
|
| Time Factors | 1 | 2004 | 39587 | 0.000 |
Why?
|
| Mutation | 1 | 2004 | 29614 | 0.000 |
Why?
|